RECRUITINGOBSERVATIONAL
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
About This Trial
The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).
Who May Be Eligible (Plain English)
Who May Qualify:
- Adult participants (≥18 years)
- Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
- Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
Who Should NOT Join This Trial:
- The participant expected not to cooperate with study procedures.
- Allergy to plaster or silicone.
- Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
- Inability to give willing to sign a consent form.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Adult participants (≥18 years)
* Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
* Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
Exclusion Criteria:
* The participant expected not to cooperate with study procedures.
* Allergy to plaster or silicone.
* Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
* Inability to give informed consent.
Treatments Being Tested
DEVICE
Vital signs measurements with new app
Patients vital signs are monitored through an app for the nurses to use
Locations (1)
Rigshospitalet
Copenhagen, Copenhagen, Denmark